Product Pipeline
Our product pipeline spans cutting-edge cell and gene therapies, including CAR-T, CAR-NK, TIL, MSC, and therapeutic cancer vaccines, driving innovation from early research to clinical translation.
Our immune cell therapies, including CAR-T, CAR-NK, and TIL, are designed to harness and enhance the body’s natural defenses, offering next-generation solutions for hematologic malignancies, solid tumors, and autoimmune diseases.
Mesenchymal stem cell (MSC) therapies are our most widely applied products, providing versatile regenerative, anti-inflammatory, and immunomodulatory benefits across degenerative, metabolic, autoimmune diseases, and wellness programs.
Our therapeutic cancer vaccine, powered by our proprietary recombinant antigen platform, targets prostate, cervical, and solid tumors with innovative antigen-specific immunotherapies that stimulate durable anti-tumor responses.